{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T08:56:53Z","timestamp":1776589013057,"version":"3.51.2"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.amjcard.2009.06.036","type":"journal-article","created":{"date-parts":[[2009,10,18]],"date-time":"2009-10-18T04:08:14Z","timestamp":1255838894000},"page":"1235-1240","source":"Crossref","is-referenced-by-count":27,"title":["Impact of Final Activated Clotting Time After Transradial Coronary Stenting With Maximal Antiplatelet Therapy"],"prefix":"10.1016","volume":"104","clinical-trial-number":[{"clinical-trial-number":"nct001169819","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00790907","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Olivier F.","family":"Bertrand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Rod\u00e9s-Cabau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Rinfret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Larose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Bagur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Proulx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onil","family":"Gleeton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Costerousse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"De Larochelli\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2009.06.036_bib1","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1161\/CIRCULATIONAHA.106.638627","article-title":"A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation","volume":"114","author":"Bertrand","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2009.06.036_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ahj.2008.02.006","article-title":"One-year clinical outcome after abciximab bolus-only compared with abciximab bolus and 12-hour infusion in the Randomized EArly Discharge after Transradial Stenting of CoronarY Arteries (EASY) study","volume":"156","author":"Bertrand","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2009.06.036_bib3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ccd.21662","article-title":"Early and late outcomes in patients excluded from same-day home discharge after transradial stenting and maximal antiplatelet therapy","volume":"72","author":"Bertrand","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2009.06.036_bib4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2009.06.036_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ahj.2008.09.010","article-title":"Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy","volume":"157","author":"Bertrand","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2009.06.036_bib6","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/eurheartj\/ehi564","article-title":"Guidelines for percutaneous coronary interventions","volume":"26","author":"Silber","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2009.06.036_bib7","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1161\/CIRCULATIONAHA.106.173220","volume":"113","author":"Smith","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2009.06.036_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0002-9149(03)00637-4","article-title":"Relation between the degree of procedural anticoagulation and complications after coronary stent implantation","volume":"92","author":"Ashby","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2009.06.036_bib9","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.amjcard.2003.08.063","article-title":"Revisiting optimal anticoagulation with unfractionated heparin during coronary stent implantation","volume":"92","author":"Brener","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2009.06.036_bib10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1067\/mhj.2002.123143","article-title":"Relationship between activated clotting time during percutaneous intervention and subsequent bleeding complications","volume":"144","author":"Hillegass","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2009.06.036_bib11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0735-1097(02)02767-5","article-title":"Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial","volume":"41","author":"Tolleson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2009.06.036_bib12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/01.CIR.93.4.667","article-title":"Relation between activated clotting time during angioplasty and abrupt closure","volume":"93","author":"Narins","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2009.06.036_bib13","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/01.CIR.0000139868.53594.24","article-title":"Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention","volume":"110","author":"Brener","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2009.06.036_bib14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ccd.10322","article-title":"Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials","volume":"57","author":"Blankenship","year":"2002","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2009.06.036_bib15","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.CIR.103.7.961","article-title":"Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials","volume":"103","author":"Chew","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2009.06.036_bib16","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/01.CIR.88.4.1569","article-title":"Vascular complications after balloon and new device angioplasty","volume":"88","author":"Popma","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2009.06.036_bib17","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1161\/01.CIR.94.12.3369","article-title":"The myth of the myocardial \u201cinfarctlet\u201d during percutaneous coronary revascularization procedures","volume":"94","author":"Abdelmeguid","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2009.06.036_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0735-1097(97)00506-8","article-title":"Myonecrosis after revascularization procedures","volume":"31","author":"Califf","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2009.06.036_bib19","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/0735-1097(95)00091-H","article-title":"Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT)","volume":"25","author":"Harrington","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2009.06.036_bib20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ccd.21345","article-title":"Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis","volume":"71","author":"Nienhuis","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2009.06.036_bib21","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0735-1097(00)00513-1","article-title":"Long-term clinical events following creatine kinase\u2014myocardial band isoenzyme elevation after successful coronary stenting","volume":"35","author":"Saucedo","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2009.06.036_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1522-726X(199910)48:2<123::AID-CCD1>3.0.CO;2-O","article-title":"Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices","volume":"48","author":"Kini","year":"1999","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2009.06.036_bib23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.CIR.101.6.604","article-title":"Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients","volume":"101","author":"Mehran","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2009.06.036_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0002-9149(03)00525-3","article-title":"Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes\u2014observations from the TARGET trial","volume":"92","author":"Casserly","year":"2003","journal-title":"Am J Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914909012624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914909012624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T19:21:42Z","timestamp":1544901702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914909012624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0002914909012624"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2009.06.036","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}